3rd Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D issues.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 23, HR 1249, PL112-29, America Invents Act.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Health Issues HCR

General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative regulatory issues. Prescription Drug User Fee Act (PDUFA) Reauthorization. Importation. Drug Safety Issues. Drug shortage.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.